Patent ID: 6908944

Claim:
A pharmaceutical composition for the treatment of an increased urge to urinate or urinary incontinence, comprising a pharmaceutically acceptable excipient and a compound of formula I: wherein X is OH, F, Cl, H or OC(O)R 7 , where R 7 is branched or unbranched, saturated or unsaturated, unsubstituted or mono- or polysubstituted C 1-3 -alkyl, and R 9 , R 10 and R 13 each independently of one another is H, F, Cl, Br, I, CH 2 F, CHF 2 , CF 3 , OH, SH, OR 14 , OCF 3 , SR 14 , NR 17 R 18 , SOCH 3 , SOCF 3 ; SO 2 CH 3 , SO 2 CF 3 , CN, COOR 14 , NO 2 , CONR 17 R 18 ; branched or unbranched, saturated or unsaturated, unsubstituted or mono- or polysubstituted C 1-6 -alkyl; or unsubstituted or mono- or polysubstituted phenyl; where R 14 is C 1-6 -alkyl; pyridyl, thienyl, thiazolyl, phenyl, benzyl or phenethyl, in each case unsubstituted or mono- or polysubstituted; PO(O—C 1-4 -alkyl) 2 , CO(OC 1-5 -alkyl), CONH—C 6 H 4 —(C 1-3 -alkyl), CO(C 1-5 -alkyl), CO—CHR 17 —NHR 18 , or CO—C 6 H 4 —R 15 , where R 15 is ortho-OCOC 1-3 -alkyl or meta- or para-CH 2 N(R 16 ) 2 , where R 16 is C 1-4 -alkyl or 4-morpholino, and R 17 and R 18 each independently of one another is H; C 1-6 -alkyl; phenyl, benzyl, or phenethyl, in each case unsubstituted or mono- or polysubstituted, wherein for R 14 , R 15 , R 16 R 17 and R 18 , the alkyl groups maybe branched or unbranched, saturated or unsaturated, unsubstituted or mono- or polysubstituted; and R 12 and R 11 form a 3,4-OCH═CH ring; wherein the compound of formula I is in the form of a racemate, an enantiomer, a diastereomer, a mixture of enantiomers, a mixture of diastereomers, a free base, or a salt of a physiologically acceptable acid.